FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits

Documenti analoghi

• FDA's Approval Process Borne Out by a Large Study: But Communicating Generics' Safety and Efficacy to the Public Leaves Much to Be Desired
  di: Buffery, Dalia
  Pubblicazione: (2010)
• First Generic ARB Approval Draws a Wave of Comparative Studies
  di: Buffery, Dalia
  Pubblicazione: (2011)
• FDA ban of generic oxycodone calls into question Health Canada’s approval
  di: Miller, Adam
  Pubblicazione: (2013)
• FDA finally approves Plan B—but with restrictions
  di: Tanne, Janice Hopkins
  Pubblicazione: (2006)
• Where Generics and Biologics Meet
  di: Heinrichs, Melisa J., et al.
  Pubblicazione: (2008)